Covid: RT-PCR accounted for over 70% tests conducted in Delhi in 5 months

RT-PCR accounted for over 70% of the total tests conducted to identify infected patients in Delhi in the last five months, according to government data

A health worker takes a swab sample at a pop-up Covid-19 testing station in the Sanlitun area of Beijing, China, on Thursday, Aug. 5, 2021. China imposed new travel and movement restrictions amid a delta-driven outbreak that's grown to over 500 sympt
Press Trust of India New Delhi
2 min read Last Updated : Sep 09 2021 | 11:41 AM IST

Don't want to miss the best from Business Standard?

RT-PCR, the most recommended method for tracing coronavirus, accounted for over 70 percent of the total tests conducted to identify infected patients in Delhi in the last five months, according to government data.

Between August 1 and August 25, health authorities conducted 16.17 lakh tests, including 11.18 lakh RT-PCR ones.

In July, 21.79 lakh COVID-19 tests were conducted in the capital. Of this, 15.18 lakh were conducted through the RT-PCR method.

RT-PCR tests accounted for 71.42 percent of the total 21.88 lakh tests conducted in June and 75.17 percent of the 21.41 lakh tests conducted in May.

In February, March and April; 64.81 percent, 64.29 percent and 66.02 percent tests were conducted through this method.

Over 20 lakh tests were conducted in January, of which 11.78 lakh (57.65 percent) were RT-PCR tests.

Real Time Polymer Chain Reaction test (RT-PCR) and Rapid Antigen Test (RAT) are two main methods used to detect coronavirus.

RT-PCR detects the viral genetic material (RNA) and is quite accurate. The results can take up to two days. The advantage of this test is that it can detect the virus even before the emergence of symptoms and allows early isolation, preventing the spread of the infection.

RAT detects viral proteins at the peak of the infection. This test is not as accurate as the standard RT-PCR test used to accurately identify those infected.A significant percentage of those infected pass the RAT test as a false negative.

The advantage is the low price and availability of the result within 30 minutes.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelta variant of coronavirusCoronavirus Vaccine

First Published: Sep 09 2021 | 11:41 AM IST

Next Story